Matches in Wikidata for { <http://www.wikidata.org/entity/Q97085509> ?p ?o ?g. }
- Q97085509 description "2020 nî lūn-bûn" @default.
- Q97085509 description "2020年の論文" @default.
- Q97085509 description "2020年学术文章" @default.
- Q97085509 description "2020年学术文章" @default.
- Q97085509 description "2020年学术文章" @default.
- Q97085509 description "2020年学术文章" @default.
- Q97085509 description "2020年学术文章" @default.
- Q97085509 description "2020年学术文章" @default.
- Q97085509 description "2020年學術文章" @default.
- Q97085509 description "2020年學術文章" @default.
- Q97085509 description "2020年學術文章" @default.
- Q97085509 description "2020年學術文章" @default.
- Q97085509 description "2020年學術文章" @default.
- Q97085509 description "2020년 논문" @default.
- Q97085509 description "article científic" @default.
- Q97085509 description "article scientific" @default.
- Q97085509 description "article scientifique" @default.
- Q97085509 description "articol științific" @default.
- Q97085509 description "articolo scientifico" @default.
- Q97085509 description "artigo científico" @default.
- Q97085509 description "artigo científico" @default.
- Q97085509 description "artigo científico" @default.
- Q97085509 description "artikel ilmiah" @default.
- Q97085509 description "artikull shkencor" @default.
- Q97085509 description "artikulong pang-agham" @default.
- Q97085509 description "artykuł naukowy" @default.
- Q97085509 description "artículo científico publicado en 2020" @default.
- Q97085509 description "artículu científicu" @default.
- Q97085509 description "bilimsel makale" @default.
- Q97085509 description "bài báo khoa học" @default.
- Q97085509 description "naučni članak" @default.
- Q97085509 description "scienca artikolo" @default.
- Q97085509 description "scientific article published on 02 July 2020" @default.
- Q97085509 description "scientific article published on 2 July 2020" @default.
- Q97085509 description "scientific article published on 2 July 2020" @default.
- Q97085509 description "teaduslik artikkel" @default.
- Q97085509 description "tieteellinen artikkeli" @default.
- Q97085509 description "tudományos cikk" @default.
- Q97085509 description "vedecký článok" @default.
- Q97085509 description "vetenskaplig artikel" @default.
- Q97085509 description "videnskabelig artikel udgivet 2. juli 2020" @default.
- Q97085509 description "vitenskapelig artikkel" @default.
- Q97085509 description "vitskapeleg artikkel" @default.
- Q97085509 description "vědecký článek" @default.
- Q97085509 description "wetenschappelijk artikel" @default.
- Q97085509 description "wissenschaftlicher Artikel" @default.
- Q97085509 description "επιστημονικό άρθρο" @default.
- Q97085509 description "мақолаи илмӣ" @default.
- Q97085509 description "наукова стаття, опублікована в липні 2020" @default.
- Q97085509 description "научна статия" @default.
- Q97085509 description "научная статья" @default.
- Q97085509 description "научни чланак" @default.
- Q97085509 description "научни чланак" @default.
- Q97085509 description "מאמר מדעי" @default.
- Q97085509 description "مقالة علمية نشرت في 2 يوليو 2020" @default.
- Q97085509 description "২ জুলাই ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q97085509 description "บทความทางวิทยาศาสตร์" @default.
- Q97085509 description "სამეცნიერო სტატია" @default.
- Q97085509 name "Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II stud" @default.
- Q97085509 name "Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II stud" @default.
- Q97085509 type Item @default.
- Q97085509 label "Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II stud" @default.
- Q97085509 label "Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II stud" @default.
- Q97085509 prefLabel "Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II stud" @default.
- Q97085509 prefLabel "Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II stud" @default.
- Q97085509 P1433 Q97085509-2FBA478A-2A55-4D38-A3AE-EAA0E83251F4 @default.
- Q97085509 P1476 Q97085509-42632CF7-719C-4EFB-9D1F-CB21C24E2D59 @default.
- Q97085509 P2093 Q97085509-0A1E5CE4-0149-48EF-BE0E-3961EC76BE96 @default.
- Q97085509 P2093 Q97085509-0EBAFAFE-3821-4D60-B156-86C72D1CCB1D @default.
- Q97085509 P2093 Q97085509-1E7B2A69-6CD9-4F98-A5CD-5EA31F881E17 @default.
- Q97085509 P2093 Q97085509-311C0632-0AC2-45E4-A9F2-2B6EBA23B21D @default.
- Q97085509 P2093 Q97085509-4E1877A7-905F-4E27-ACBE-FBA6FFF79B98 @default.
- Q97085509 P2093 Q97085509-5A8FD722-3682-4B1B-9346-2D693F24CA25 @default.
- Q97085509 P2093 Q97085509-6063885E-A4C3-4F91-8D1E-ED2C77726AB9 @default.
- Q97085509 P2093 Q97085509-62CA81AB-B5CC-40A6-A3F8-0F0B24AF20DC @default.
- Q97085509 P2093 Q97085509-6DC80E66-BABD-4D84-8247-472E721C67BA @default.
- Q97085509 P2093 Q97085509-768DC131-D0B0-4BEF-BD19-88F2F240440B @default.
- Q97085509 P2093 Q97085509-7749E8F6-3856-48DC-BF4A-231624777908 @default.
- Q97085509 P2093 Q97085509-7F5CA261-CA5C-49C1-B1D4-68C7FB4DF2CE @default.
- Q97085509 P2093 Q97085509-8438164D-34F5-4FFD-B1E0-04865CA78727 @default.
- Q97085509 P2093 Q97085509-85D2CF22-3EBD-4F54-A602-6E2DC031C5D4 @default.
- Q97085509 P2093 Q97085509-9355DA6E-7C50-44CC-8230-433379A23D5F @default.
- Q97085509 P2093 Q97085509-984798A3-1A3B-4E4E-AD33-44C39ED272DD @default.
- Q97085509 P2093 Q97085509-B1689C64-5C73-4743-990F-03458A3B0F53 @default.
- Q97085509 P2093 Q97085509-CBF4074E-836C-4609-B9F0-5A217E650627 @default.
- Q97085509 P2093 Q97085509-E4D6388B-4AB9-4D70-86FF-51FC0785678B @default.
- Q97085509 P304 Q97085509-833F88C9-4EC8-4DD7-A517-FDDCE4FD26E8 @default.
- Q97085509 P31 Q97085509-C4571CFB-9EB7-4070-B296-CC09B1A5658C @default.
- Q97085509 P356 Q97085509-4AB3A9E0-4FBB-4A2C-B0E8-F2816D0FD211 @default.
- Q97085509 P478 Q97085509-A9E2ED27-D717-4EEC-835C-DC7C80DB955C @default.
- Q97085509 P50 Q97085509-7C0F7D71-C07F-4509-A27F-48D198E270A8 @default.
- Q97085509 P577 Q97085509-40783689-307F-4339-BBA7-B316992E2D19 @default.
- Q97085509 P698 Q97085509-0B19E5E2-C0E2-4396-A2DA-E8149EF42798 @default.
- Q97085509 P921 Q97085509-09C075B4-1AB0-4649-9C00-D698BA49BEC2 @default.
- Q97085509 P921 Q97085509-60B431B5-031D-4B21-B711-D15422E8CC5D @default.
- Q97085509 P356 J.EJCA.2020.05.018 @default.
- Q97085509 P698 32623182 @default.
- Q97085509 P1433 Q332260 @default.
- Q97085509 P1476 "Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)" @default.
- Q97085509 P2093 "Alain Gratet" @default.